Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma

Stock Information for Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A)

Concord Medical Schedules 2025 Annual Meeting of Shareholders
Concord Medical Reports Financial Results for the First Half of 2025
Concord Healthcare Announces Official Release of the Proton Therapy Large Model
Concord Medical Files Annual Report on Form 20-F for Fiscal 2024
Concord Medical Announces Result of 2024 Annual General Meeting
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
Concord Medical Schedules 2024 Annual Meeting of Shareholders
Concord Medical Reports Financial Results for the First Half of 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.